RAFASSAL 500 MG SUPPOSITORIES Israel - English - Ministry of Health

rafassal 500 mg suppositories

rafa laboratories ltd - mesalazine - suppositories - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

PENTASA SUPPOSITORIES Israel - English - Ministry of Health

pentasa suppositories

ferring pharmaceuticals ltd - mesalazine - suppositories - mesalazine 1000 mg - mesalazine - mesalazine - ulcerative proctitis.

RAFASSAL 1 GRAM CAPLETS Israel - English - Ministry of Health

rafassal 1 gram caplets

rafa laboratories ltd - mesalazine - gastro resistant caplets - mesalazine 1000.0 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

RAFASSAL 1 GRAM SUPPOSITORIES Israel - English - Ministry of Health

rafassal 1 gram suppositories

rafa laboratories ltd - mesalazine - suppositories - mesalazine 1000 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

RAFASSAL 1 GRAM ENEMA Israel - English - Ministry of Health

rafassal 1 gram enema

rafa laboratories ltd - mesalazine - enema - mesalazine 1 g - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

PENTASA SLOW RELEASE GRANULES 2 G Israel - English - Ministry of Health

pentasa slow release granules 2 g

ferring pharmaceuticals ltd - mesalazine - granules - mesalazine 2 g/sachet - mesalazine - mesalazine - mild to moderate ulcerative colitis or crohn's disease.

ASACOL mesalazine 800 mg enteric coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

asacol mesalazine 800 mg enteric coated tablets blister pack

chiesi australia pty ltd - mesalazine, quantity: 800 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; purified talc; povidone; methacrylic acid copolymer; triethyl citrate; iron oxide yellow; iron oxide red; macrogol 6000 - for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.

ASACOL mesalazine 400 mg enteric coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

asacol mesalazine 400 mg enteric coated tablets blister pack

chiesi australia pty ltd - mesalazine, quantity: 400 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; purified talc; povidone; methacrylic acid copolymer; triethyl citrate; iron oxide yellow; iron oxide red; macrogol 6000 - for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.

Asacolon 1600 mg modified-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

asacolon 1600 mg modified-release tablets

tillotts pharma gmbh - mesalazine - modified-release tablet - 1600 milligram(s) - aminosalicylic acid and similar agents; mesalazine

MESALAZINE RMB mesalazine 1.2 g gastro-resistant prolonged release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mesalazine rmb mesalazine 1.2 g gastro-resistant prolonged release tablet blister pack

southern cross pharma pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; methacrylic acid copolymer; hypromellose; purified talc; colloidal anhydrous silica; iron oxide red; povidone; titanium dioxide; triethyl citrate; ammonia; magnesium stearate; pregelatinised maize starch - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis